Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alprazolam ODT Preference in Anxiety
NCT00139854Phase 3Completed
- Sponsor
- UCB
- Start
- Aug 2004
- Primary completion
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of alprazolam in anxiety disorder (2 arms), sponsored by UCB. Primary endpoint: Subject Preference Questionnaire. Started Aug 2004; status: completed.
02
Drugs
alprazolam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT00139854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139854.